Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is Halbert, Christine L  [Clear All Filters]
B
Blankinship, MJ, Gregorevic P, Allen JM, Harper SQ, Harper H, Halbert CL, Miller AD, Miller AD, Chamberlain JS.  2004.  Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.. Molecular therapy : the journal of the American Society of Gene Therapy. 10(4):671-8. Abstract
H
Halbert, CL, Allen JM, Miller AD.  2002.  Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.. Nature biotechnology. 20(7):697-701. Abstract
Halbert, CL, Miller AD.  2004.  AAV-mediated gene transfer to mouse lungs.. Methods in molecular biology (Clifton, N.J.). 246:201-12. Abstract
Halbert, CL, Miller AD, McNamara S, Emerson J, Gibson RL, Ramsey B, Aitken ML.  2006.  Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.. Human gene therapy. 17(4):440-7. Abstract
Halbert, CL, Lam S-L, Miller AD.  2007.  High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung.. Human gene therapy. 18(4):344-54. Abstract
Halbert, CL, Madtes DK, Vaughan AE, Wang Z, Storb R, Tapscott SJ, Miller AD.  2010.  Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs.. Molecular therapy : the journal of the American Society of Gene Therapy. 18(6):1165-72. Abstract
L
Liu, S-L, Halbert CL, Miller AD.  2004.  Jaagsiekte sheep retrovirus envelope efficiently pseudotypes human immunodeficiency virus type 1-based lentiviral vectors.. Journal of virology. 78(5):2642-7. Abstract
S
Seiler, MP, Miller AD, Zabner J, Halbert CL.  2006.  Adeno-associated virus types 5 and 6 use distinct receptors for cell entry.. Human gene therapy. 17(1):10-9. Abstract
V
Vaughan, AE, Halbert CL, Wootton SK, Miller AD.  2012.  Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activation.. Molecular cancer research : MCR. 10(1):86-95. Abstract
W
Wang, Z, Storb R, Halbert CL, Banks GB, Butts TM, Finn EE, Allen JM, Miller AD, Chamberlain JS, Tapscott SJ.  2012.  Successful Regional Delivery and Long-term Expression of a Dystrophin Gene in Canine Muscular Dystrophy: A Preclinical Model for Human Therapies.. Molecular therapy : the journal of the American Society of Gene Therapy. Abstract
Wootton, SK, Halbert CL, Miller AD.  2005.  Sheep retrovirus structural protein induces lung tumours.. Nature. 434(7035):904-7. Abstract
Wootton, SK, Halbert CL, Miller AD.  2006.  Envelope proteins of Jaagsiekte sheep retrovirus and enzootic nasal tumor virus induce similar bronchioalveolar tumors in lungs of mice.. Journal of virology. 80(18):9322-5. Abstract
Y
Yu, DL, Linnerth-Petrik NM, Halbert CL, Walsh SR, Miller AD, Wootton SK.  2011.  Jaagsiekte sheep retrovirus and enzootic nasal tumor virus promoters drive gene expression in all airway epithelial cells of mice but only induce tumors in the alveolar region of the lungs.. Journal of virology. 85(15):7535-45. Abstract